Immunocompromised

15 registered clinical trials studyying Immunocompromised — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients NCT07391046	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Not Yet Recruiting	Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients NCT06615635	Alpha Tau Medical LTD.	N/A
Recruiting	Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special P NCT07120464	Liaoning Chengda Biotechnology CO., LTD	—
Not Yet Recruiting	Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immun NCT06610643	National Taiwan University Hospital	N/A
Withdrawn	A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weak NCT05545319	Pfizer	Phase 2
Terminated	A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COV NCT05074433	Regeneron Pharmaceuticals	Phase 3
Completed	COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the Unite NCT05020145	Pfizer	—
Recruiting	Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT NCT03808922	Ansun Biopharma, Inc.	Phase 3
Recruiting	Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease NCT03425526	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy NCT03168815	Mount Sinai Hospital, Canada	N/A
Completed	Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients NCT03262584	Karius, Inc.	—
Terminated	A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis NCT02057289	Children's Hospital Medical Center, Cincinnati	Phase 1
Completed	Seasonal Flu Vaccine in Adult Transplant Recipients NCT01258023	HepNet Study House, German Liverfoundation	Phase 2
Unknown	Diagnosis of Invasive Pulmonary Aspergillosis by Direct Lung Tissue Aspergillus Galactomannan Antigen Detectio NCT01301755	National Taiwan University Hospital	—
Terminated	H1N1sw Vaccine in Adult Transplant Recipients NCT01069601	HepNet Study House, German Liverfoundation	Phase 2